Safety of immunization during pregnancy: A review of the evidence of selected inactivated and live attenuated vaccines

Vaccine

Volumn 32, Issue 52, 2014, Pages 7057-7064

  Keller Stanislawski, Brigitte ^a   Englund, Janet A ^b   Kang, Gagandeep ^c   Mangtani, Punam ^d   Neuzil, Kathleen ^e,f   Nohynek, Hanna ^f   Pless, Robert ^g   Lambach, Philipp ^h   Zuber, Patrick ^h  

^a PAUL EHRLICH INSTITUT   (Germany)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF WASHINGTON   (United States)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Inactivated vaccine; Live attenuated vaccine; Maternal vaccination; Vaccine safety

Indexed keywords

DIPHTHERIA TOXOID; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; POLYSACCHARIDE VACCINE; TETANUS TOXOID; YELLOW FEVER VACCINE; BACTERIAL VACCINE; INACTIVATED VACCINE; VIRUS VACCINE;

CONGENITAL MALFORMATION; CONSENSUS; DRUG SAFETY; FETUS RISK; FEVER; HEADACHE; HUMAN; MASS IMMUNIZATION; MORBIDITY; MYALGIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; REVIEW; SPONTANEOUS ABORTION; TERATOGENICITY; ADVERSE EFFECTS; FEMALE; VACCINATION;

BACTERIAL VACCINES; FEMALE; HUMANS; PREGNANCY; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 84915776207     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.09.052     Document Type: Review

References (107)

1. Jamieson D.J., Theiler R.N., Rasmussen S.A. Emerging infections and pregnancy. Emerg Infect Dis J 2006, 12(11):1638-1643.
2. Vaccines against influenza WHO position paper-November 2012. Wkly Epidemiol Rec 2012;87(47):461-76.
3. Tetanus vaccine. Wkly Epidemiol Rec 2006;81(20):198-208.
4. Ortiz J., Englund J.A., Neuzil D.M. Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine 2011, 29(27):4439-4452.
5. Neuzil K.M., Reed G.W., MitchelE.F.Simonson L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998, 148(11):1094-1102.
6. Mosby L.G., Rasmussen S.A., Jamieson D.J. Pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011, 205(1):10-18.
7. Mak T.K., Mangtani P., Leese J., Watson J.M., Pfeiffer D. Influenza vaccination in pregnancy: current evidence for influenza vaccination during pregnancy and selected countries' national policies. Lancet Infect Dis 2008, 8(1):44-52.
8. Hartert T.V., Neuzil K.M., Shintani A.K., Mitchell E.F., Snowden M.S., Wood L.B., et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 2003, 189(6):1705-1712.
9. van Kerkhove M.D., Vandemaele K.A., Shinde V., Jaramillo-Gutierrez G., Koukounari A., Donnelly C.A., et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011, 8(7):e1001053. WHO Working Group for Risk Factors for Severe H1N1pdm Infection.
10. Harris J. Influenza occurring in pregnant women: a statistical study of 130 cases. J Am Med Assoc 1919, 72(14):978-980.
11. Freeman D.W., Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959, 578:1172-1175.
12. Neuzil K.M., Griffin M.R., Schaffner W. Influenza vaccine: issues and opportunities. Infect Dis Clin North Am 2001, 15(1):123-141.
13. McNeil S.A., Dodds L.A., Fell D.B., Allen V.M., Halperin B.A., Steinhoff M.C., et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol 2011, 204(6 Suppl. 1):S54-S57.
14. Mendez-Figueroa H., Raker C., Anderson B.L. Neonatal characteristics and outcomes of pregnancies complicated by influenza infection during the 2009 pandemic. Am J Obstet Gynecol 2011, 204(6 Suppl. 1):S58-S63.
15. Pierce M., Kurinczuk J.J., Spark P., Brocklehurst P., Knight M. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. Br Med J 2011, 342:d3214. UKOSS.
16. Håberg S.E., Trogstad L., Gunnes N., Wilcox A.J., Gjessing H.K., Samuelsen S.O., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013, 368:333-340.
17. ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. Br Med J 2010, 340(c1279):1-6.
18. Rasmussen S.A., Jamieson D.J., Uyeki T.M. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 2012, 207(Suppl. 3):S3-S8.
19. Steinhoff M.C., Omer S.B. A review of fetal and infant protection associated with antenatal influenza immunization. Am J Obstet Gynecol 2012, 207(Suppl. 3):S21-S27.
20. Omer S.B., Goodman D., Steinhoff M.C., Rochat R., Klugman K.P., Stoll B.J., et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011, 8(5):e1000441.
21. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564.
22. Eick A.A., Uyeki T.M., Klimov A., Hall H., Reid R., Santosham M., et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011, 165(2):104-111.
23. Sheffield J.S., Greer L., Rogers V., Roberts S.W., Lytle H., McIntire D., et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol 2012, 120(3):532-537.
24. Poehling K.A., Szilagyi P.G., Staat M.A., Snively B.M., Payne D.C., Bridges C.B., et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011, 204(Suppl 6):S141-S148.
25. Steinhoff M.C., Omer S.B., Roy E., El Arifeen S., Raqib R., Dodd C., et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012, 184(April (6)):645-652.
26. Jackson L.A., Patel S.M., Swamy G.K., Frey S.E., Creech C.B., Munoz F.M., et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 2011, 204(6):854-863.
27. Moro P.L., Broder K., Zheteyeva Y., Walton K., Rohan P., Sutherland A., et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol 2011, 204(2). 146.e1-146.e7.
28. Heinonen O.P., Shapiro S., Monson R.R., Hartz S.C., Rosenberg L., Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973, 2(3):229-235.
29. Heinonen O.P., Slone D., Shapiro S. Immunizing agents. Birth defects and drugs in pregnancy 1977, 314-321. Publishing Sciences Group Inc., Littleton, MA. D.W. Kaufman (Ed.).
30. Hulka J.F. Effectiveness of polyvalent influenza vaccine in pregnancy. Report of a controlled study during an outbreak of Asian influenza. Obstet Gynecol 1964, 23:830-837.
31. Munoz F.M. Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol 2012, 207(Suppl. 3):S33-S37.
32. Tamma P.D., Ault K.A., del Rio C., Steinhoff M.C., Halsey N.A., Omer S.B. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009, 201(6):547-552.
33. Kharbanda E.O., Vazquez-Benitez G., Shi W.X., Lipkind H., Naleway A., Monitor B., Klucker L., et al. Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink. Am J Obstet Gynecol 2012, 207(Suppl. 3):S47-S51.
34. Bednarczyk R.A., Adjaye-Gbewonyo D., Omer S.B. Safety of influenza immunization during pregnancy for the fetus and neonate. Am J Obstet Gynecol 2012, 207(Suppl. 3):S38-S46.
35. Mosby L.G., Ellington S.R., Forhan S.E., Yeng L.F., Yeung L.F., et al. The Centers for Disease Control and Prevention's maternal health response to 2009 H1N1 influenza. Am J Obstet Gynecol 2011, 204(Suppl. 1):S7-S12.
36. Omon E., Damase-Michel C., Hurault-delarue C., Larcoix I., Montastruc J.L., Oustric S., et al. Non-adjuvanted 2009 influenza A (H1N1) vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine 2011, 29(52):9649-9654.
37. Moro P.L., Tepper N.K., Gohskopf L.A., Vellozzi C., Broder K. Safety of seasonal influenza and influenza A (H1N1) monovalent vaccines in pregnancy. Expert Rev Vaccines 2012, 11(8):911-921.
38. Lim S.H., Lee J.H., Kim B.C., Jung S.U., Park Y.B., Lee C.S. Adverse reaction of influenza A (H1N1) 2009 virus vaccination in pregnant women and its effect on newborns. Vaccine 2010, 28:7455-7456.
39. Horiya M., Hirsano M., Iwasaki Y., Hanoka M., Watanabe N., Ito Y., et al. Efficacy of double vaccination with the 2009 pandemic influenza A (H1N1) vaccine during pregnancy. Obstet Gynecol 2011, 118(4):887-894.
40. Heikkinen T., Young J., van Beek E., Franke H., Verstraeten T., Weil J.G., et al. Safety of MF-59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012, 207(3):177.e1-177.e8.
41. Tsai T., Kyaw M.H., Novicki D., Nacci P., Rai S., Clemens R. Exposure to MF59-adjuvanted influenza vaccines during pregnancy-a retrospective analysis. Vaccine 2010, 28(7):1877-1880.
42. Rubinstein F., Micone P., Bonotti A., Wainer V., Schwarcz A., Augustovski F., et al. Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. Br Med J 2013, 346:f393. EVA Study Research Group Estudio Embarazo y Vacuna Antigripal.
43. Puleston R., Bugg G., Hoschler K., Konje J., Thornton J., Stephenson I., et al. Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with ASO31-adjuvanted H1N1 2009 vaccine. PLoS One 2013, 8(1):e47448.
44. Pasternak B., Svanström H., Mølgaard-Nielsen D., Krause T.G., Emborg H.D., Melbye M., et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A (H1N1) vaccine during pregnancy. J Am Med Assoc 2012, 308(2):165-174.
45. Pasternak B., Svanström H., Mølgaard-Nielsen D., Krause T.G., Emborg H.D., Melbye M., et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. Br Med J 2012, 344:e2794.
46. Sammon C.J., Snowball J., McGrogan A., de Vries C.S. Evaluating the hazard of foetal death following H1N1 influenza vaccination: a population based cohort study in the UK GPRD. PLoS One 2012, 7(12):e51734. 10.1371/journal.pone.0051734.
47. Mackenzie I.S., Mcdonald T.M., Shakir S., Dryburgh M., Mantay B.J., McDonnell P., et al. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. Br J Clin Pharmacol 2011, 73(5):801-811.
48. Tavares F., Nazareth I., Monegal J.S., Kolte I., Verstraeten T., Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine 2011, 29(37):6358-6365.
49. ® during pregnancy and delivery outcome: a Swedish register study. Int J Gynaecol Obstet 2012, 119:1583-1590.
50. Makris M.C., Polyzos K.A., Mavros M.N., Athanasiou S., Rafailidis P.I., Falagas M.E. Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Saf 2012, 35(1):1-14.
51. O'Dempsey T.J., McArdle T., Ceesay S.J., Secka O., Demba E., Banya W.A., et al. Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy. Arch Dis Child Fetal Neonatal Ed 1996, 74(81):F43-F46.
52. Obaro S.K., Deubzer H.E., Newman V.O., Adegbola R.A., Greenwood B.M., Henderson D.C. Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy. Pediatr Infect Dis J 2004, 23(11):1023-1029.
53. McCormick J.B., Gusmão H.H., Nakamura S., Freire J.B., Veras J., Gorman G., et al. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy. J Clin Invest 1980, 65(5):1141-1144.
54. O'Dempsey T.J.D, McArdle T., Ceesay S.J., Banya W.A.S., Demba E., Secka O., et al. Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy. Vaccine 1996, 14(10):962-970.
55. Ouandaogo C.R., Yaméogo T.M., Diomandé F.V., Sawadogo C., Ouédraogo B., Ouédraogo-Traoré R., et al. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010. Vaccine 2012, 30(Suppl. 2):B46-B51.
56. Zheteyeva Y., Moro P.L., Yue X., Broder K. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2013, 208(6):478.e1-478.e6.
57. List of Pregnancy Exposure Registries. U.S. Food and Drug Administration, [10.11.2014 11:31:38]. http://www.fda.gov/ScienceResearch/SpecialTopics/WomensHealthResearch/ucm134848.htm.
58. Demicheli V., Barale A., Rivetti A. Vaccines for women to prevent neonatal tetanus. Cochrane Rev 2008, 2:CD002959. http://apps.who.int/rhl/reviews/CD002959.pdf (accessed 2 April 2013).
59. Freda V.J. A preliminary report on typhoid, typhus, tetanus, and cholera immunizations during pregnancy. Am J Obstet Gynecol 1956, 71(5):1134-1136.
60. Dastur F.D., Awatramani V.P., Chitre S.K., D'Sa J.A. A single dose vaccine to prevent neonatal tetanus. J Assoc Physicians India 1993, 41(2):97-99.
61. Czeizel A.E., Rockenbauer M. Tetanus toxoid and congenital abnormalities. Int J Gynaecol Obstet 1999, 64(3):253-258.
62. Silveira C.M., Cáceres V.M., Dutra M.G., Lopes-Camelo J., Castilla E.E. Safety of tetanus toxoid in pregnant women: a hospital-based case-control study of congenital anomalies. Bull World Health Organ 1995, 73(5):605-608.
63. Salama M.M., Hady O.A., Ashour W., Mostafa A., El Alkamy S., El Sayed N., et al. A randomized controlled trial administration of tetanus toxoid (TT) versus tetanus and reduced diphtheria (Td) in pregnant women. J Clin Immunol 2009, 29(4):524-531.
64. Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce MP et al., Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Erratum in MMWR Morb Mortal Wkly Rep. 2008;57(26):723.
65. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria, and acellular pertussis vaccine (Tdap) in pregnant women. Advisory Committee on Immunization Practices (ACIP), 2012. Morb Mortal Wkly Rep 2013, 62(07):131-135.
66. Joint Committee of Vaccination and Immunisation. Minute of teleconference on Thursday Wednesday 30 August 2012 10.00am-12.00am and post-teleconference discussion. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/223497/JCVI_minutes_Aug_2012_Pertussis_-_final.pdf.
67. Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effects on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011, 204(334):e1-e5.
68. Zheteyeva Y.A., Moro P.L., Tepper N.K., Rasmussen S.A., Barash F.E., Revzina N.V., et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012, 207(1):59.e1-59.e7.
69. Donegan K., King B., Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014, 349:g4219. 10.1136/bmj.g4219.
70. Elimination of Maternal and Neonatal Tetanus|Health|UNICEF.[10.11.2014 11:13:53]. http://www.unicef.org/health/index_43509.html.
71. Enders G. Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy. Rev Infect Dis 1985, 7(Suppl 1):S103-S107.
72. Bart S.W., Stetler H.C., Preblud S.R., Williams N.M., Orenstein W.A., Bart K.J., et al. Fetal risk associated with rubella vaccine: an update. Rev Infect Dis. 1985, 7(Suppl 1):S95-S102.
73. Bar-Oz B., Levichek Z., Moretti M., Mah C., Andreou S., Koren G. Pregnancy outcome following rubella vaccination: a prospective controlled study. Am J Med Genet 2004, 130A(1):52-54.
74. Da Silva e Sa G.R., Camacho L.A., Stavola M.S., Lemos X.R., Basílio de Oliveira C.A., Siqueira M.M. Pregnancy outcomes following rubella vaccination: a prospective study in the state of Rio de Janeiro, Brazil, 2001-2002. J Infect Dis 2011, 204(Suppl.2):S722-S728.
75. Badilla X., Morice A., Avila-Aguero M.L., Saenz E., Cerda I., Reef S., et al. Fetal risk associated with rubella vaccination during pregnancy. Pediatr Infect Dis J 2007, 26(9):830-835.
76. Minussi L., Mohrdieck R., Bercini M., Ranieri T., Sanseverino M.T., Momino W., et al. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil. Reprod Toxicol 2008, 25(1):120-123.
77. Pardon F., Vilariño M., Barbero P., Garcia G., Outon E., Gil C., et al. Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina. J Infect Dis 2011, 204(Suppl. 2):S745-S747.
78. Soares R.C., Siqueira M.M., Toscano C.M., Maia Mde L., Flannery B., Sato H.K., et al. Follow-up study of unknowingly pregnant women vaccinated against rubella in Brazil, 2001-2002. J Infect Dis 2011, 204(Suppl. 2):S729-S736.
79. Hamkar R., Jalilvand S., Abdolbaghi M.H., Esteghamati A.R., Hagh-Goo A., Jelyani K.N., et al. Inadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccine. Vaccine 2006, 24(17):3558-3563.
80. Sato H.K., Sanajotta A.T., Moraes J.C., Andrade J.Q., Duarte G., Cervi M.C., et al. Rubella vaccination of unknowingly pregnant women: the Sao Paulo experience, 2001. J Infect Dis 2011, 204(Suppl. 2):S737-S744. São Paulo Study Group for Effects of Rubella Vaccination During Pregnancy.
81. Kroger A.T., Atkinson W.L., Marcuse E.K., Pickering L.K. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(RR-15):1-48. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).
82. Castillo-Solórzano C., Reef S.E., Morice A., Vascones N., Chevez A.E., Castalia-Soares R., et al. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008. J Infect Dis 2011, 204(Suppl. 2):S713-S717.
83. Wyll S.A., Herrmann K.L. Inadvertent rubella vaccination of pregnant women: fetal risk in 215 cases. J Am Med Assoc 1973, 225(12):1472-1476.
84. Hofmann J., Kortung M., Pustowoit B., Faber R., Piskazeck U., Liebert U.G. Persistent fetal rubella vaccine virus infection following inadvertent vaccination during early pregnancy. J Med Virol 2000, 61(1):155-158.
85. Plotkin S., Orenstein W., Offit P. Vaccines 2008, Saunders, Philadelphia, PA. 5th ed.
86. Horstmann D.M., Opton E.M., Klempferer R., Llado B., Vignec A.J. Viremia in infants vaccinated with oral polio vaccine (Sabin). Am J Hyg 1964, 79:47-63.
87. Burton A.E., Robinson E.T., Harper W.F., bell E.J., Boyd J.F. Fetal damage after accidental polio vaccination of an immune mother. J R Coll Gen Pract 1984, 34(264):390-394.
88. Harjulehto T., Aro T., Hovi T., Saxén L. Congenital malformations and oral poliovirus vaccination during pregnancy. Lancet 1989, 333(8641):771-772.
89. Harjulehto-Mervaala T., et al. Oral polio vaccination during pregnancy: no increase in the occurrence of congenital malformations. Am J Epidemiol 1993, 138(6):407-414.
90. Ornoy A., Ishai P.B. Congenital anomalies after oral poliovirus vaccination during pregnancy. Lancet 1993, 341(8853):1162.
91. Linder N., Handsher R., Fruman O., Shiff E., Ohel G., Reichman B., et al. Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity. Pediatr Infect Dis J 1994, 13(11):959-962.
92. Harjulehto-Mervaala T., Aro T., Hiilesmaa V.K., Hovi T., Saxén H., Saxén L. Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome. Clin Infect Dis 1994, 18(3):414-420.
93. Harjulehto-Mervaala T., Hovi T., Aro T., Saxén H., Hiilesmaa V.K. Oral poliovirus vaccination and pregnancy complications. Acta Obstetrica et Gynecologica Scandinavica 1995, 74(4):262-265.
94. Harjulehto-Mervaala T. Oral polio vaccination and pregnancy outcome 1997, University of Helsinki, Helsinki, [dissertation].
95. Ornoy A., Arnon J., Feingold M., Ben Ishai P. Spontaneous abortions following oral poliovirus vaccination in first trimester. Lancet 1990, 335(8692):800.
96. Staples J.E. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practise (ACIP). MMWR Recomm Rep 2010, 59:1-279.
97. World Health Organization International travel and health 2012, World Health Organization, Geneva, http://www.who.int/ith/chapters/ith2012en_chap6.pdf.
98. Cavalcanti D.P., Salomão M.A., Lopez-Camelo J., Pessoto M.A. Early exposure to yellow fever vaccine during pregnancy. Trop Med Int Health 2007, 12:833-837. Campinas Group of Yellow Fever Immunization during Pregnancy.
99. Suzano C.E., Amaral E., Sato H.K., Papaiordanou P.M. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil. Vaccine 2006, 24:1421-1426. Campinas Group on Yellow Fever Immunization during Pregnancy.
100. Tsai T.F., Paul R., Lynberg M.C., Letson G.W. Congenital yellow fever virus infection after immunization in pregnancy. J Infect Dis 1993, 168:1520-1523.
101. Robert E., Vial T., Schaefer C., Arnon J., Reuvers M. Exposure to yellow fever vaccine in early pregnancy. Vaccine 1999, 17:283-285.
102. D'Acremont V., Tremblay S., Genton B. Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study. J Travel Med 2008, 15:77-81.
103. Nishioka Sde A., Nunes-Araújo F.R., Pires W.P., Silva F.A., Costa H.L. Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study. Trop Med Int Health 1998, 3:29-33.
104. Thomas R.E., Lorenzetti D.L., Spragins W., Jackson D., Williamson T. The safety of yellow fever vaccine 17D and 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review. Am J Trop Med Hyg 2012, 86:359-372.
105. Nasidi A., Monath T.P., Vandenberg J., Tomori O., Calisher C.H., Hurtgen X., et al. Yellow fever vaccination and pregnancy: a four year prospective study. Trans R Soc Trop Med Hyg 1993, 87:337-339.
106. Orenstein L.A., Orenstein E.W., Teguete I., Kodio M., Tapia M., Sow S.O., et al. Background rates of adverse pregnancy outcomes for assessing the safety of maternal vaccine trials in sub-Saharan Africa. PLoS One 2012, 7(10):e46638.
107. Sammon C.J., McGrogan A., Snowball J., deVries C.S. Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: an analysis using the General Practice Research Database. Vaccine 2012, 30(14):2483-2489.